Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
American Journal of Nephrology|December 5, 2003
Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancerMindy A Maynard, Michael OhhJournal of Biomedicine & Biotechnology|December 19, 2002
Playing Tag with HIF: The VHL StorySherri K. Leung, Michael OhhEMBO Reports|March 8, 2008
NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHLRyan C Russell, Michael OhhDiscover Oncology|October 28, 2024
Glucose deprivation impairs hypoxia-inducible factor-1α synthesisMia Hubert, Sarah Stuart, Michael OhhScientific Reports|June 26, 2024
Cathepsins L and B target HIF1α for oxygen-independent proteolytic cleavageSarah Stuart, Daniel Tarade, Michael OhhNature Communications|July 25, 2019
Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2αDaniel Tarade, Jeffrey E Lee, Michael OhhCancer Cell|February 15, 2011
NEDD8 pathways in cancer, Sine Quibus NonIan R Watson, Meredith S Irwin, Michael OhhPlos One|October 3, 2013
SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptorSevera Bunda, Kamya Kommaraju, Pardeep Heir, et al.American Journal of Physiology. Renal Physiology|June 8, 2004
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinomaRoxana I Sufan, Michael A S Jewett, Michael OhhElife|August 30, 2022
Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmataMichael Ohh, Cassandra C Taber, Fraser G Ferens, et al.Pageof 8